Peter Wessman

741 total citations
18 papers, 555 citations indexed

About

Peter Wessman is a scholar working on Physiology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Peter Wessman has authored 18 papers receiving a total of 555 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Physiology, 6 papers in Surgery and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Peter Wessman's work include Asthma and respiratory diseases (7 papers), Advanced Statistical Process Monitoring (5 papers) and Scientific Measurement and Uncertainty Evaluation (5 papers). Peter Wessman is often cited by papers focused on Asthma and respiratory diseases (7 papers), Advanced Statistical Process Monitoring (5 papers) and Scientific Measurement and Uncertainty Evaluation (5 papers). Peter Wessman collaborates with scholars based in Sweden, United States and United Kingdom. Peter Wessman's co-authors include Gene Colice, Karin Bowen, Edward Piper, Reynold A. Panettieri, Ulf Sjöbring, Christopher E. Brightling, Marianne Frisén, Finn Waagstein, John Kjekshus and John Wikstrand and has published in prestigious journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and Kidney International.

In The Last Decade

Peter Wessman

16 papers receiving 513 citations

Peers

Countries citing papers authored by Peter Wessman

Since Specialization

Citations

This map shows the geographic impact of Peter Wessman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Wessman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Wessman more than expected).

Fields of papers citing papers by Peter Wessman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Wessman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Wessman. The network helps show where Peter Wessman may publish in the future.

Co-authorship network of co-authors of Peter Wessman

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Wessman. A scholar is included among the top collaborators of Peter Wessman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Wessman. Peter Wessman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	The randomized DIALIZE-Outcomes trial evaluated sodium zirconium cyclosilicate in hemodialysis 2025 ·Kidney International ·Steven Fishbane, Laura M. Dember, Michel Jadoul, Csaba P. Kövesdy, Nicolás Guzmán, (unknown), Vera Lisovskaja, Priya Sekar, Peter Wessman, Ayman Al‐Shurbaji, Charles A. Herzog	0
2	The Trajectory of Renal Function Following Mechanical Circulatory Support and Subsequent Heart Transplantation 2022 ·ESC Heart Failure ·(unknown), (unknown), Peter Wessman, Göran Dellgren, Kristjan Karason	5
3	The risk of revision following total hip arthroplasty in patients with inflammatory bowel disease, a registry based study 2021 ·PLoS ONE ·(unknown), Peter Wessman, Ola Rolfson, Daniel D. Bohl, Johan Kärrholm, Ali Keshavarzian, Dale R. Sumner	13
4	Reduced risk of clinically important deteriorations by ICS in COPD is eosinophil dependent: a pooled post-hoc analysis 2020 ·Respiratory Research ·Mona Bafadhel, Dave Singh, Christine Jenkins, Stefan Peterson, Thomas Bengtsson, Peter Wessman, Malin Fagerås	17
5	Application of structured statistical analyses to identify a biomarker predictive of enhanced tralokinumab efficacy in phase III clinical trials for severe, uncontrolled asthma 2019 ·BMC Pulmonary Medicine ·Mattis Gottlow, (unknown), Ilya Lipkovich, (unknown), Karin Bowen, Peter Wessman, Gene Colice	9
6	Corticosteroid tapering with benralizumab treatment for eosinophilic asthma: PONENTE Trial 2019 ·ERJ Open Research ·Andrew Menzies‐Gow, Jonathan Corren, Elisabeth H. Bel, Jorge Máspero, Liam G. Heaney, Mark Gurnell, Peter Wessman, Ubaldo J. Martin, Shahid Siddiqui, Esther García Gil	39
7	Oral Corticosteroid Tapering During Benralizumab Treatment of Severe, Uncontrolled Eosinophilic Asthma: PONENTE Phase IIIb Clinical Trial 2019 ·Andrew Menzies‐Gow, Jonathan Corren, Elisabeth H. Bel, Jorge Máspero, Liam G. Heaney, Mark Gurnell, Peter Wessman, Una Martin, Salman Siddiqui, Esther García Gil	2
8	Tralokinumab for severe, uncontrolled asthma (STRATOS 1 and STRATOS 2): two randomised, double-blind, placebo-controlled, phase 3 clinical trials 2018 ·The Lancet Respiratory Medicine ·Reynold A. Panettieri, Ulf Sjöbring, (unknown), Peter Wessman, Karin Bowen, Edward Piper, Gene Colice, Christopher E. Brightling	177
9	Effect of tralokinumab on GINA control in severe, uncontrolled asthma 2017 ·Christopher E. Brightling, Edward Piper, Peter Wessman, Gene Colice	1
10	A Nonsteroidal Glucocorticoid Receptor Agonist Inhibits Allergen-induced Late Asthmatic Responses 2014 ·American Journal of Respiratory and Critical Care Medicine ·Gail M. Gauvreau, Louis‐Philippe Boulet, Richard Leigh, Donald W. Cockcroft, Kieran J. Killian, Beth E. Davis, Francine Deschesnes, Richard M. Watson, Veronica A. Swystun, Carina Kärrman Mårdh, Peter Wessman, Carin Jorup, Magnus Aurivillius, Paul M. O’Byrne	24
11	Safety and tolerability of an immediate-release formulation of the oral direct thrombin inhibitor AZD0837 in the prevention of stroke and systemic embolism in patients with atrial fibrillation 2010 ·Thrombosis and Haemostasis ·(unknown), Arnljot Tveit, Eva C. Jensen, Peter Wessman, (unknown), Karin Wåhlander, (unknown)	47
12	Risk of recurrent venous thromboembolism or bleeding in relation to thrombophilic risk factors in patients receiving ximelagatran or placebo for long‐term secondary prevention of venous thromboembolism 2006 ·British Journal of Haematology ·Karin Wåhlander, Henry Eriksson, Torbjörn Lundström, (unknown), Ulrika Wall, Per Nyström, Peter Wessman, Sam Schulman, (unknown)	13
13	A Statin in the Treatment of Heart Failure? Controlled Rosuvastatin Multinational Study in Heart Failure (CORONA): Study Design and Baseline Characteristics 2005 ·European Journal of Heart Failure ·John Kjekshus, Peter Dunselman, (unknown), (unknown), Åke Hjalmarson, John J.V. McMurray, Finn Waagstein, Hans Wedel, Peter Wessman, John Wikstrand	120
14	Some power aspects of methods for detecting different shifts in the mean 2000 ·Communications in Statistics - Simulation and Computation ·(unknown), Peter Wessman	8
15	The surveillance of several processes with different change points 1999 ·Gothenburg University Publications Electronic Archive (Gothenburg University) ·Peter Wessman	9
16	Evaluations of likelihood ratio methods for surveillance. 1999 ·Communications in Statistics - Simulation and Computation ·Marianne Frisén, Peter Wessman	39
17	Some principles for surveillance adopted for multivariate processes with a common change point 1998 ·Communication in Statistics- Theory and Methods ·Peter Wessman	31
18	Evaluation of univariate surveillance procedures for some multivariate problems 1996 ·Gothenburg University Publications Electronic Archive (Gothenburg University) ·Peter Wessman	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact